日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CircUCK2(2,3) promotes cancer progression and enhances synergistic cytotoxicity of lenvatinib with EGFR inhibitors via activating CNIH4-TGFα-EGFR signaling

CircUCK2(2,3) 通过激活 CNIH4-TGFα-EGFR 信号传导促进癌症进展并增强仑伐替尼与 EGFR 抑制剂的协同细胞毒性

Xindong Wei #, Anfeng Si #, Shuai Zhao #, Yi Fu, Jilei Li, Kedeerya Aishanjiang, Yujie Ma, Chang Yu, Bo Yu, Chunhong Cui, Hui Wang, Xianming Kong, Shibo Li, Xiaoni Kong, Ying Tong, Hailong Wu4

Overlapping Syndrome of Myocarditis, Myositis, Transaminitis, and Myasthenia Gravis in a Patient with Hepatocellular Carcinoma after Treatment with Immune Checkpoint Inhibitors: A Case Report and Literature Review

肝细胞癌患者接受免疫检查点抑制剂治疗后出现心肌炎、肌炎、转氨酶升高和重症肌无力重叠综合征:病例报告及文献综述

Kalifu, Baheti; Meng, Yuan; Aishanjiang, Kedeerya; Ma, Chao; Tian, Guang-Lei; Wang, Jin-Guo; Ma, Zhi-Gang; Chen, Xiong

Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data

基于多期增强CT和临床数据的深度学习在恶性肝肿瘤鉴别诊断中的应用

Gao, Ruitian; Zhao, Shuai; Aishanjiang, Kedeerya; Cai, Hao; Wei, Ting; Zhang, Yichi; Liu, Zhikun; Zhou, Jie; Han, Bing; Wang, Jian; Ding, Han; Liu, Yingbin; Xu, Xiao; Yu, Zhangsheng; Gu, Jinyang